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Background: D-QuiNAc is found in many important bacteria, but its biosynthesis has not been defined.
Results: UDP-D-QuiNAc was synthesized in vitro from UDP-D-GlcNAc in reactions catalyzed by two cloned enzymes.
Conclusion: R. etli CE3 protein WreQ has UDP-2-acetamido-2,6-dideoxy-D-xylo-4-hexulose 4-reductase activity.
Significance: The defined pathway for UDP-D-QuiNAc biosynthesis provides this compound for in vitro biosynthetic studies
and predicts organisms that contain D-QuiNAc.
N-acetyl-D-quinovosamine (2-acetamido-2,6-dideoxy-D-glu-
cose, QuiNAc) occurs in the polysaccharide structures of many
Gram-negative bacteria. In the biosynthesis of QuiNAc-con-
taining polysaccharides, UDP-QuiNAc is the hypothetical
donor of theQuiNAc residue. Biosynthesis of UDP-QuiNAc has
been proposed to occur by 4,6-dehydration of UDP-N-acetyl-
D-glucosamine (UDP-GlcNAc) to UDP-2-acetamido-2,6-dide-
oxy-D-xylo-4-hexulose followed by reduction of this 4-keto
intermediate toUDP-QuiNAc. Several specific dehydratases are
known to catalyze the first proposed step. A specific reductase
for the last step has not been demonstrated in vitro, but previous
mutant analysis suggested that Rhizobium etli genewreQmight
encode this reductase. Therefore, this gene was cloned and
expressed in Escherichia coli, and the resulting His6-tagged
WreQproteinwas purified. It was tested for 4-reductase activity
by adding it and NAD(P)H to reaction mixtures in which 4,6-
dehydratase WbpM had acted on the precursor substrate
UDP-GlcNAc. Thin layer chromatography of the nucleotide
sugars in the mixture at various stages of the reaction showed
that WbpM converted UDP-GlcNAc completely to what was
shown to be its 4-keto-6-deoxy derivative by NMR and that
addition of WreQ and NADH led to formation of a third com-
pound. Combined gas chromatography-mass spectrometry
analysis of acid hydrolysates of the final reaction mixture
showed that a quinovosaminemoiety hadbeen synthesized after
WreQ addition. The two-step reaction progress also was moni-
tored in real time by NMR. The final UDP-sugar product after
WreQ addition was purified and determined to be UDP-D-
QuiNAc by one-dimensional and two-dimensional NMR exper-
iments. These results confirmed that WreQ has UDP-2-acet-
amido-2,6-dideoxy-D-xylo-4-hexulose 4-reductase activity,
completing a pathway for UDP-D-QuiNAc synthesis in vitro.
Many rare sugars are found in the polysaccharide structures
coating bacterial cell surfaces. A moderately rare example is
N-acetyl-D-quinovosamine (QuiNAc),3 which so far has been
found exclusively in the lipopolysaccharides (LPSs) or capsular
polysaccharides of bacteria. Although confined to bacteria, it is
found in numerous species, including species belonging to the
genera Pseudomonas and Rhizobium (1, 2).
TheQuiNAc residue of LPS inRhizobium etli strainCE3may
play an important role in the biology of this bacterium. An R.
etli mutant strain (CE166) carrying a Tn5 transposon in the
wreQ gene locus (formerly designated lpsQ) fails in the infec-
tion stage of symbiosis with legume hosts. This mutant has
much less O-antigen-containing LPS than normal, and its
O-antigen lacks QuiNAc (3, 4). The QuiNAc is replaced in this
mutant by its 4-keto derivative, 2-acetamido-2,6-dideoxy-D-
xylo-4-hexulose (5). The deficiency in O-antigen amount can
be suppressed by introducing into this mutant multiple copies
of the other R. etli CE3 genes needed for O-antigen synthesis.
Because QuiNAc is still replaced in the resulting strain by its
4-keto derivative, the effect of just this abnormality is thereby
revealed. The mutant genetically suppressed in this way infects
slowly, and resulting root nodules are widely dispersed (4). This
result suggests that the symbiotic role of LPS may require a
specific structural feature conferred by QuiNAc.
QuiNAc has been proposed to be the first sugar of the O-an-
tigen of R. etli CE3 and the O-antigen-repeating unit in Pseu-
domonas aeruginosaO6 (6–8). However, these inferences lack
evidence from biosynthesis of the polysaccharide in vitro. One
obstacle to such studies is that the expected biosynthetic donor
of the QuiNAc residue, UDP-QuiNAc, has never been pro-
duced in vitro.
The proposed biosynthetic pathway of UDP-QuiNAc, based
on studies in R. etli CE3 and in P. aeruginosaO6 (5, 6), involves
two steps. In the first step, the precursor UDP-GlcNAc is con-
verted by a 4,6-dehydratase to its 4-keto-6-deoxy derivative.
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This reaction has been reproduced in vitro by use of several
homologous enzymes (9–13). It is the common first step in
synthesizing many UDP-sugars from UDP-GlcNAc (14).
In the proposed second step, the 4-keto intermediate is fur-
ther converted toUDP-QuiNAc by a 4-reductase. This reaction
and an enzyme to catalyze it have never been demonstrated in
vitro. It has been proposed that the R. etli CE3 wreQ gene
encodes the 4-reductase for this step. This gene was previously
designated lpsQ (5), but all genes involved in R. etli CE3 O-an-
tigen synthesis have been assigned the symbol wre to conform
to bacterial polysaccharide genetic nomenclature (15). The pre-
dicted amino acid sequence suggests that WreQ belongs to the
short chain dehydratase/reductase superfamily characterized
by its GXXGXXG nucleotide-binding motif and the SYK cata-
lytic triad (5, 16). As mentioned above, chemical analysis of
O-antigen from the symbiosis-deficient wreQ-null mutant
showed that QuiNAc was replaced by its 4-keto derivative at
the same position (5), supporting thatWreQ is the 4-reductase
for the last step in QuiNAc synthesis.
P. aeruginosa serotypeO6 containsQuiNAc in theO-antigen
of its B-bandLPS.AwreQ gene homolog,wbpV, was found in its
B-band O-antigen gene cluster. Disruption of the wbpV gene
abrogates O-antigen synthesis (6). P. aeruginosa O6 also con-
tains thewbpM gene, which encodes a UDP-GlcNAc 4,6-dehy-
dratase (6). The enzymatic activity of WbpM has been demon-
strated in vitro biochemically (9, 13). The R. etli CE3 genome
contains awbpM gene homolog designatedwreV. A logical pre-
diction is that these gene pairs (wreV and wreQ in R. etli CE3
and wbpM and wbpV in P. aeruginosaO6) encode the enzymes
needed to synthesize QuiNAc.
In thework presented here, theR. etliCE3WreQproteinwas
purified, and its enzymatic activity in vitro was investigated.
The nucleotide sugar product of the WreQ-catalyzed reaction
was chemically identified to be UDP-D-QuiNAc. The results
confirmed that WreQ can act as a 4-reductase to provide the
first demonstration of UDP-D-QuiNAc synthesis in vitro.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions—R. etli CE3 was
derived from R. etli type strain CFN42 by a spontaneous muta-
tion conferring resistance to streptomycin (17). As in all past
studies ofwreQ and almost all other studies of the LPS of R. etli
CFN42, strain CE3 was the wild-type source of DNA and geno-
type for strain constructions. All R. etli strains were grown to
stationary phase at 30 °C in TY liquid medium (0.5% tryptone
(Difco), 0.3% yeast extract (Difco), and 10 mM CaCl2). Unless
stated otherwise, all Escherichia coli strains were grown to sta-
tionary phase at 37 °C in Luria-Bertani (LB) liquid medium
(1.0% tryptone, 0.5% yeast extract, and 0.5% NaCl). Agar
medium contained 1.5% Bacto Agar (Difco).
DNA Techniques—R. etli genomic DNA was isolated using a
GenElute Bacterial Genomic DNA kit (Sigma-Aldrich). Plas-
mid DNA isolation from E. coli cultures and purification from
agarose gels were performed using the QIAprep SpinMiniprep
kit (Qiagen) and Gel/PCR DNA Fragments Extraction kit (IBI
Scientific), respectively. Amounts of DNA fragments were
amplified using the Expand High Fidelity PCR System (Roche
Applied Science) with custom primers (Eurofins MWG
Operon) containing restriction sites to facilitate cloning.
Restriction enzymes and T4 DNA ligase were purchased from
New England Biolabs. Vectors or recombinant plasmids were
transformed intoOmniMAX (Invitrogen) or 5- (NewEngland
Biolabs) E. coli cells for cloning or into BL21(DE3) (Lucigen)
E. coli cells for protein overexpression. DNA sequencing was
performed by Functional Biosciences.
Construction of a pET Vector forWreQOverexpression—The
gene encodingWreQ was amplified from the genomic DNA of
R. etli CE3 (NCBI accession number NC_007761; the wreQ
gene sequence (nucleotide 2969313 to nucleotide 2970242)
under this accession matches exactly with the lpsQ sequence
under GenBankTM accession number AY391267 reported pre-
viously (5)). The primers designed based on this DNA sequence
are 5-CCGGCATATGCGATGCCTCGTCACC-3 (forward)
and 5-GGCCGGATCCCTATTCCACTGCAAG-3 (reverse).
Restriction sites included in the primers are underlined. The
wreQ gene was subcloned by insertion at the NdeI and BamHI
sites of pET15b vector (Novagen), generating plasmid pLS7.
The resulting construct was checked by restriction digestion
and nucleotide sequence determination. It encodes the WreQ
protein with additional amino acids at the amino terminus,
MGSSHHHHHHSSGLVPRGSH (the His6 tag is underlined,
and the thrombin cleavage site is in bold). TheWreQ protein is
referred to as His6-WreQ in this work.
Complementation of R. etli wreQ Mutant—For testing com-
plementation of a wreQ mutant with his6-wreQ, the his6-wreQ
gene together with the vector ribosome binding site was ampli-
fied from the constructed vector pLS7 with primers 5-GCC-
GAATTCATACCCACGCCGAAACAAG-3 (forward) and 5-
GCCGGTACCAGTTCCTCCTTTCAGCAAA-3 (reverse).
This fragment was subcloned by insertion into the EcoRI and
KpnI sites of plasmid pFAJ1708 (18), generating plasmid pLS31.
The pLS31 plasmid was introduced into the R. etli wreQ::Tn5
mutant CE166 by a triparental mating procedure described
previously (8). LPS was prepared from 0.5 ml of full-grown cul-
tures and analyzed by SDS-PAGE with periodate-silver stain
(8). To determine whether QuiNAc was present, LPS was extr-
acted from washed bacterial pellets (from 4.0 liters of culture)
by the hot phenol-water method; dialyzed; treated with RNase
A, DNase I, and protease K; and dialyzed again followed by
lyophilization (8). For determination of neutral and amino su-
gars, LPS preparations were treated with 2 M trifluoroacetic
acid for 2 h at 121 °C. After reduction with NaBD4 and acetyl-
ation, alditol acetate derivatives of the LPS sugars were ana-
lyzed by gas chromatography (GC) under conditions described
previously (8).
To test complementation of a wreQmutant with wbpV from
P. aeruginosaO6, pFV611-26 plasmid (6) (provided by Dr. J. S.
Lam, University of Guelph, Guelph, Canada) was digested with
PstI and SacI to release a fragment containing the wbpV gene.
This fragment was cloned into two pFAJ1700-based vectors
(18), generating pJB7 and pJB8, respectively. Complementation
was tested as described above.
Mutagenesis of R. etli wreV Gene and Its Complementation
with wbpM Gene of P. aeruginosa—Site-directed mutagenesis
of R. etli wreV gene was performed using the same method as
described in the previous study (8). The gentamicin resistance
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cassette from plasmid pUCGm (19) was inserted in the R. etli
CE3 wreV gene through the SalI sites, generating strain CE568.
To test complementation of the wreV mutant with wbpM
from P. aeruginosa, the full-length wbpM gene was amplified
from a pBAD-wbpM vector (provided by Dr. J. S. Lam) with
primers 5-GGCATATGTTGGATAATTTGAGG-3 (for-
ward) and 5-TTAAGCTTTCAGGGTTCTCGCCGCC-3 (re-
verse). This fragment was subcloned by insertion into the NdeI
and HindIII sites of plasmid pJBC1 (20), generating plasmid
pTL61. Complementation was tested as described above.
Overexpression and Purification of His6-WreQ—The pLS7
plasmid encoding His6-WreQ was transformed into electro-
competent BL21(DE3) E. coli cells by electroporation, and a
purified transformant was grown overnight in LBmedium con-
taining ampicillin (100 g/ml). A flask of 1 liter of LB medium
was inoculated with 5 ml of overnight culture and grown at
37 °C with shaking until A600 reached 0.6. His6-WreQ expres-
sion was induced by adding isopropyl -D-1-thiogalactopyra-
noside (Gold Biotechnology) to a final concentration of 0.1mM,
and the culturewas shaken for a further 20 h at 16 °C. Cells were
harvested by centrifugation at 5000 g for 15 min at 4 °C, and
the pellets were stored at80 °C until needed.
TheHis6-WreQproteinwas purifiedwithNi2 affinity chro-
matography. Specifically, the frozen cell pellets were resus-
pended in lysis buffer (20mM sodiumphosphate, 300mMNaCl,
5 mM imidazole, and 14.3 mM 2-mercaptoethanol, pH 7.0) and
disrupted by sonication. Cell debris was removed by centrifu-
gation (6000  g for 20 min at 4 °C), and the supernatant was
centrifuged at 65,000 g for 120 min at 4 °C. The supernatant
was passed through a column containing 1ml of Ni2 Profinity
immobilized metal affinity chromatography resin (Bio-Rad).
The column was washed with 10 ml of lysis buffer followed by
washing with lysis buffer containing 20 mM imidazole. His6-
WreQ protein was eluted with lysis buffer containing 300 mM
imidazole. Triton X-100 was added to the combined elution
fraction to a final concentration of 0.1%. Then the elution frac-
tion was transferred to dialysis tubing (molecular mass cutoff,
12–14,000 Da) and dialyzed overnight at 4 °C in 1 liter of buffer
containing 20 mM sodium phosphate, 300 mM NaCl, and 14.3
mM 2-mercaptoethanol, pH 7.0. The dialyzed protein sample
was concentratedwith anAmiconUltra-15 (nominalmolecular
mass limit, 10 kDa) filter device. The concentrated protein was
fast frozen on dry ice and preserved at80 °Cuntil needed. The
typical yield of purified protein was 4.5 mg/liter of cell culture.
Protein concentration was determined by the method of Brad-
ford (21).
Overexpression, Purification, and Enzymatic Analysis of
WbpM—The E. coli BL21(DE3)plysS strain carrying a pET vec-
tor derivative encoding a soluble truncated version of the
WbpM protein (residues 262–665) (9) was generously pro-
vided byDr. J. S. Lam. To express theWbpM-His-S262 protein,
1 liter of LB medium was inoculated with a 20-ml overnight
culture of the BL21(DE3)plysS strain and grown at 37 °C. Pro-
tein expression was induced by addition of 0.5 mM isopropyl
-D-1-thiogalactopyranoside. After a 5-h induction at 37 °C,
the cellswere harvested by centrifugation at 5000 g for 15min
at 4 °C. Purification of WbpM-His-S262 was carried out in the
samemanner as described above for His6-WreQ except that all
the buffers did not contain 2-mercaptoethanol. Following puri-
fication, the elution fraction was dialyzed against 1 liter of
buffer (20 mM sodium phosphate and 300 mM NaCl, pH 7.0)
and concentratedwith anAmiconUltra-15 (nominalmolecular
mass limit, 10 kDa) filter device. Protein concentration was
determined by the method of Bradford (21).
Radioactive enzyme assays were carried out in 10-l reac-
tions containing 20 mM sodium phosphate, pH 7.0, 0.5 mM
UDP-GlcNAc (Sigma), 0.029 M UDP-[3H]GlcNAc (0.1 mCi/
mmol; PerkinElmer Life Sciences), and 9 g of WbpM. The
reaction was incubated at 30 °C and allowed to proceed for 30
min for complete substrate conversion.
WbpM-WreQCoupled EnzymeAssay—TheWreQ-catalyzed
reaction was carried out by adding 15g of His6-WreQ protein
and 1 mM NAD(P)H to the WbpM reaction mixture and
allowed to proceed for another 4 h. In the control reactions
where one or multiple components were omitted, the lost vol-
ume was compensated with buffer.
Separation of Sugar Nucleotides by Thin Layer Chroma-
tography—Enzyme reactions were stopped by adding an equal
volumeof ice-cold 100%ethanol, and proteinswere removed by
centrifugation (16,000  g for 10 min at 4 °C) after overnight
storage at20 °C. The supernatant was lyophilized to dryness
and stored at20 °C.
The dried residues of radioactive reactions were dissolved in
5 l of glass-distilled water. The entire volume of each reaction
sample was spotted on an aluminum-backed precoated Silica
Gel 60 plate (EMD Chemicals) and developed in Solvent A
(2-propanol/ammonium hydroxide/water, 6:3:1). Dried TLC
plates were sprayed with EN3HANCE Autoradiography
Enhancer (PerkinElmer Life Sciences) and exposed to film
(Eastman Kodak Co. BioMax XAR film) for 3 days at80 °C.
Gas Chromatography-Mass Spectrometry (GC-MS) Analysis
of Glycosyl Residue—To detect the glycosyl residue of the final
product of theWbpM-WreQ reaction, the reaction was carried
out in a volume of 200l containing 1mMUDP-GlcNAc, 20g
of WbpM, 36 g of His6-WreQ, and 1 mM NADH. The lyoph-
ilized reaction mixture was treated with 1 M hydrochloric acid
for 15 min at 100 °C. After reduction with NaBD4 and acetyla-
tion, alditol acetate derivatives of sugars in the reaction were
dissolved in dichloromethane and injected onto an HP-5MS
(Agilent 19091S-433E) capillary column (0.25-mm inner diam-
eter 30m, 0.25-m film thickness) with helium as the carrier
gas at a flow rate of 1.0 ml/min. The GC program was started
with an oven temperature of 50 °C followed by an increase of
20 °Cmin1 to 150 °C, then at 2 °Cmin1 to 200 °C, then at 5 °C
min1 to 260 °C, and a hold at 260 °C for 10 min.
Purification of Nucleotide Sugars by Thin Layer Chroma-
tography—To purify the non-radioactive WbpM reaction
product for NMR analysis, the reaction was incubated at 30 °C
for 1 hwith a total volume of 500l consisting of 20mM sodium
phosphate buffer, pH 7.0, 1 mM UDP-GlcNAc, and 120 g of
WbpM. To purify the final product of the WbpM-WreQ reac-
tion, 450g of His6-WreQ and 1mMNADHwere added to the
WbpM reaction and further incubated for 4 h. Reactions were
stopped and treated as described above, and after lyophiliza-
tion, the dried residues were dissolved in a 50-l volume in
water. Of this solution, 24l (0.24mol) was spotted on a TLC
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plate (10 spots, 2 l each) and developed in Solvent A as
described above. One loaded lane of the TLC plate was excised
from both sides of the TLC plate, sprayed with thymol reagent
(5 mg/ml thymol in ethanol/concentrated sulfuric, 19:1 (v/v)),
and incubated in a 110 °C oven until stained spots were
observed to locate the position of the sugar nucleotide to be
purified. At this position on the unstained part of the sameTLC
plate, the silica coating was scraped from the aluminum back-
ing, and the sugar nucleotide candidates were eluted from the
silica with Solvent A. The eluates were lyophilized and redis-
solved in 20l of water. The result of purification was analyzed
by TLC with thymol staining, and the concentration was mea-
sured by UV absorbance at 260 nm.
NMR Spectroscopy—NMR experiments were performed at a
static magnetic field strength of 14.1 teslas (proton Larmor fre-
quency of 600 MHz) on an Agilent VNMRS instrument
equipped with a ColdProbe. Standard TOCSY, gradient-en-
hanced COSY, and NOESY two-dimensional pulse sequences
were used for assignments; the pulse sequences were obtained
from the VNMRJ 2.0 software suite. Raw NMR data were pro-
cessed using NMRPipe (22) and analyzed in Sparky (23). The
NMR assignment experiments were performed at 30 °C to
match conditions of the enzyme reaction directlymonitored by
NMR. In the assignment experiments, 99% D2O was used as a
solvent with presaturation of the residual water signal. The
FIGURE 1.Coomassie Blue-stained SDS-PAGE (15%gel) showing purified
proteins His6-WreQ (A) and WbpM-His-S262 (B) used for in vitro biosyn-
thesis of UDP-QuiNAc. The apparent size of the purified His6-WreQ protein
agreed with its predicted size of 35.3 kDa. The apparent size of the purified
WbpM-His-S262 protein is consistent with the published result (9) (46.1 kDa).
FIGURE 2. Complementation of the R. etli wreQmutant strain, CE166. A, silver-stained SDS-PAGE (18% gel) of LPS samples fromwhole-cell lysates. Lane 1,
CE3; lane 2, CE166; lane 3, CE166/pLS31; lane 4, CE166/pJB7; lane 5, CE166/pJB8. LPS I, O-antigen-containing LPS; LPS II, core oligosaccharide-Lipid A lacking
O-antigen. B and C, relative content of QuiNAc among the sugars of crude LPS as revealed by GC analysis after conversion of sugars to alditol acetates. CE3,
wild-typeR. etli strain;CE166,R. etli strainwith a Tn5 insertion inwreQ;CE166/pLS31, CE166 strain carryingpLS31vector,whichexpressesHis6-WreQ;CE166/pJB7
and CE166/pJB8, CE166 strain carrying pJB7 or pJB8 plasmids, each carrying thewbpV gene. QuiN, quinovosamine.
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chemical shifts measured at 30 °C were referenced to the water
resonance because its temperature dependence is well known:
the water chemical shift was calculated to be at 4.700 ppm at
30 °C (24, 25). As an additional reference, we recorded the
chemical shift of the acetonemethyl group in water at the same
temperature; it was 2.201 0.008 ppm.
NMR samples were prepared by dissolution of lyophilized
powders in 99.8% D2O (Cambridge Isotope Laboratories). The
final concentration of UDP-QuiNAc in the Shigemi tube sam-
ple was 0.23 mM. The one-dimensional proton spectrum was
acquired with water presaturation, 16,384 points, and 128 tran-
sients (8 min of total acquisition time). All two-dimensional
experiments were acquiredwith 16,384 points in direct and 512
points in indirect dimensions. The two-dimensional 1H-1H
gradient-enhanced COSY was acquired in the real mode with
32 transients (5 h). The two-dimensional 1H-1H TOCSY was
acquiredwith 16 transients (11 h). The two-dimensional 1H-1H
NOESY was acquired with 16 transients in duplicate (total of
24 h). The final concentration of the 4-keto intermediate was
significantly lower than that of UDP-QuiNAc, and this was par-
tially compensated by increased acquisition time.
RESULTS
Cloning, Expression, and Purification of WreQ—The wreQ
gene was amplified from chromosomal DNA of R. etli CE3 and
cloned into the pET15b vector. The resultant plasmid encodes
a WreQ protein with an amino-terminal six-histidine tag. Fol-
lowing overexpression, this His6-WreQ protein was purified
from the soluble fraction by nickel affinity chromatography
(Fig. 1A).
FIGURE 3. Autoradiograms of TLC-separated WbpM-WreQ reaction and
control reactions. Lane 1, no enzymes were added to the nucleotide sugar
substrate UDP-GlcNAc; lane 2, WbpM reaction for synthesizing the 4-keto
intermediate; lane 3, WbpM-WreQ reaction for synthesizing UDP-QuiNAc;
lane 4, NADPH in place of NADH; lane 5, negative control, no WbpM; lane 6,
negative control, no WreQ; lane 7, no NAD(P)H. NMR analysis confirmed the
identities of the spots as follows: Spot I, UDP-GlcNAc; Spot II, 4-keto interme-
diate; Spot III, UDP-QuiNAc. * indicates NADPH.
FIGURE 4.GC-MS analysis of chemical derivatives after converting sugars to alditol acetates. A, GC profile of derivatives from theWbpM-WreQ reaction
products. B, MS spectrumof theQuiNAc derivative peak inA. Inset, predictedMS fragmentation patterns of the alditol acetates derived fromQuiNAc.MSpeaks
corresponding to thepredicted fragmentationpattern are shownwithnumbers above. Thepeakdesignatedwith& inA is a commonnon-sugar peak. Thepeak
designated with # may have resulted from other components in the enzyme reaction.
Biosynthesis of UDP-D-QuiNAc
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The modified wreQ gene (his6-wreQ) was determined to be
functional in vivo due to its ability to complement an R. etli
wreQmutant strain. In the complemented mutant, the level of
smooth LPS (LPS I) was restored to normal (Fig. 2A), and the
presence of quinovosamine in the LPS was confirmed by sugar
composition analysis (Fig. 2B). Gene wbpV, the wreQ gene
homolog from P. aeruginosa O6, also complemented the same
mutant (Fig. 2, A and C). All of these results match those
reported previously (5) when R. etliwild-typewreQwas used to
complement this same wreQmutant.
Generation ofWreQ Substrate, the 4-Keto-6-deoxyDerivative
of UDP-GlcNAc—A soluble truncated version of the WbpM
protein, His-S262 (9), was used to synthesize the predicted sub-
strate for WreQ. Purified His-S262 protein (Fig. 1B) converted
UDP-GlcNAc to a new compound, which was separated by
TLC and detected by autoradiography (Fig. 3, lanes 1 and 2).
The same result was observed on a thymol-stained TLC plate.
The new compound was purified from unstained TLC plates,
and its one-dimensional and two-dimensional 1HNMR spectra
(discussed below) agreed with the results of previous studies on
theWbpMhomologCj1120c (PglF) (13). The evidence that this
product is the 4-keto-6-deoxy derivative of UDP-GlcNAc is
presented below.
Substrate Conversion by WreQ—The strategy for assaying
WreQ was to carry out a two-step reaction. Following the first
step reaction catalyzed byWbpM, purified His6-WreQ protein
and NAD(P)H were added to start the second step reaction. A
new compound later shown to be UDP-QuiNAc was produced
(Fig. 3, lanes 3 and 4). Both the WreQ enzyme and NAD(P)H
were required to produce this new compound (Fig. 3, lanes 6
and 7). WreQ did not use UDP-GlcNAc as substrate; i.e. no
conversion occurred in the absence of WbpM (Fig. 3, lane 5).
GC-MS Analysis of the WbpM-WreQ Reaction Product—To
gain initial evidence that UDP-QuiNAc was synthesized in the
WbpM-WreQ reaction, the reaction mixture was treated at
100 °C with acid to release the sugars from the nucleoside
diphosphate linkages. The resulting compounds were reduced
and acetylated to convert sugars into deuterated alditol acetates
followed by combined GC-MS analysis.
A deuterated alditol acetate derivative eluted at 26.61 min
(Fig. 4A). It fragmented into ions with m/z ratios 85, 103, and
145, which identified it as a 2-amino sugar, and ions with m/z
ratios 201, 260, and 302 (Fig. 4B), which were 58 mass units
smaller than the corresponding ions of the alditol acetate
derived from glucosamine (data not shown). This difference
agreed exactly with predicted differences at the C6 position
where the glucosamine derivative is CH2OCOCH3 (molecular
mass, 73 Da) and quinovosamine derivative is CH3 (molecular
mass, 15 Da). These data supported the existence of the quino-
vosamine moiety in the reaction mixture as expected if UDP-
QuiNAc is produced.
NMR Analysis of the WreQ Reaction Product UDP-D-
QuiNAc—Compounds in a non-radioactive WbpM-WreQ
reaction mixture were separated by TLC, and the UDP-
QuiNAc candidate was purified from an unstained TLC plate.
FIGURE 5. Structural determination for UDP-QuiNAc. A, structure and proton NMR resonance assignments of the reaction product deduced to be UDP-D-
QuiNAc. B–D, two-dimensional 1H-1H TOCSY, COSY, and NOESY analysis of UDP-QuiNAc. B, two-dimensional 1H-1H TOCSY correlation map for UDP-QuiNAc.
C, two-dimensional 1H-1H COSY correlation map for UDP-QuiNAc. The experiment was acquired in real time mode; therefore, all resonances with chemical
shifts beyond water appear mirrored. D, two-dimensional 1H-1H NOESY correlation map for UDP-QuiNAc.
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The purified compound was analyzed by one- and two-dimen-
sional NMR spectroscopy (Figs. 5 and 6).
Assignment of proton resonances of the WreQ reaction
product utilized a combination of NOE, TOCSY, and COSY
correlations. The two-dimensional 1H-1H TOCSY experiment
allowed establishing the resonance frequencies of all protons in
the QuiNAc sugar ring (Fig. 5B). The UDP-ribose ring protons
were observed between 4.174 and 4.344 ppm and at 5.959 ppm.
The proton at 5.959 ppm was correlated to the uracil base pro-
ton at 7.935 ppm (not shown). The UDP resonances did not
significantly change from UDP-GlcNAc to the 4-keto interme-
diate and toUDP-QuiNAc; they will not be discussed. Contam-
inants uncoupled from UDP-QuiNAc resonances were ob-
served in small amounts in theUDP-QuiNAc sample as isolated
spin systems at low intensity between 3.624 and 3.814 ppm, at
1.677 and 2.144 ppm, and at 1.221 ppm (Fig. 5B). The hexose
protons assigned to the UDP-QuiNAc resonance chemical
shifts (Table 1) are explained below.
The methyl proton doublet centered at 1.271 ppm was iden-
tified as H6 by comparison with the proton spectrum of
UDP-GlcNAc that shows the only methyl resonance at 2.044
ppmoriginating from itsN-acetyl group. Inspection of the two-
dimensional 1H-1HCOSY revealed that the neighbor ofH6, the
H5 proton, resonates at 3.977 ppm (Fig. 5C). The peak of H5
had significant asymmetry, indicating overlapping resonances,
and showed four COSY cross-peaks.
The proton resonance at 5.442 ppmwas assigned to beH1 by
similarity to other sugar nucleotides (26). Inspection of the two-
dimensional 1H-1H NOESY correlation map (Fig. 5D) reveals a
strong (and the only) NOE cross-peak of H1 at 5.442 and 3.977
ppm, indicating that H5 must be overlapping with H2 at this
chemical shift because H5 is too far away to produce NOE to
H1. (In the COSY data, the H1 resonance was mirrored into
the 4.0 ppm region, thus obscuring the expected cross-peak
with H2.)
Of the two remaining resonances at 3.723 and 3.231 ppm, we
assignedH4 to 3.231 according to the following considerations.
1) The TOCSY cross-peak of H6-H3 is weaker comparatively
with the H6-H4 cross-peak in accord with the greater number
of bonds separating H6 and H3 spins (Fig. 6A, top panel). 2) An
opposite relationship is observed for TOCSY cross-peaks of
H1-H3 and H1-H4, the latter being the weakest of the two,
corresponding to the greater number of intervening bonds (Fig.
6A, bottom panel). 3) This resonance is absent in the 4-keto
intermediate, which would not have a proton at position 4 (see
Fig. 6B).
The configuration of the H4 and H5 in UDP-QuiNAc was
determined to be axial based on analysis of 3J coupling con-
stants. Both H3 and H4 are symmetrical triplets, indicating
FIGURE 6.Assignment of proton chemical shifts for H3 andH4. A, strips of
two-dimensional 1H-1H TOCSY correlation map for UDP-QuiNAc and one-
dimensional slices taken at frequencies of H6 (top panel) and H1 (bottom
panel) in indirect dimension demonstrating relative intensities of the cross-
peaks. B, comparison of one-dimensional proton NMR spectra of purified
UDP-QuiNAc (top trace) and UDP-2-acetamido-2,6-dideoxy--D-xylo-4-hexu-
lose (UDP-4-keto sugar) (bottom trace).
TABLE 1
Summaryof theproton chemical shifts andmultiplet structures for thehexose ringofUDP-D-QuiNAcandUDP-2-acetamido-2,6-dideoxy-D-xylo-
4-hexulose at 30 °C
Standard deviation of the chemical shift values is on the order of 0.004 ppm (as reported by Sparky). Accuracy of J coupling constant estimates is 0.2 Hz for
UDP-D-QuiNAc and 0.6 Hz for UDP-2-acetamido-2,6-dideoxy-D-xylo-4-hexulose.
Compound Proton Chemical shift Multiplet structure J coupling constants
ppm Hz
UDP-D-QuiNAc H1 5.422 1:1:1:1 quadruplet 3JH1,H2 3.63JH1,P 7.2
H2 3.978 Unresolved overlapped multiplet
H3 3.723 1:2:1 triplet 3JH3,H4 9.83JH2,H3 9.8
H4 3.231 1:2:1 triplet 3JH3,H4 9.33JH4,H5 9.3
H5 3.977 Unresolved overlapped multiplet
H6 1.271 1:1 doublet 3JH6,H5 6.0
UDP-2-acetamido-2,6-dideoxy-D-xylo-4-hexulosea H1 5.433 Poorly resolved multiplet
H2 4.091 Unresolved overlapped multiplet 3JH3,H2 10.8
H3 3.803 Doublet
H5 4.091 Unresolved overlapped multiplet
H6 1.218 Doublet 3JH6,H5 5.4
a Due to a lower concentration of the latter sample, the spectral quality did not allow confident measurement of the smaller 3J coupling constants at H1 position.
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identical 3J coupling constants of 9–10 Hz for all H2-H3,
H3-H4, and H4-H5 pairs (Fig. 6B, top trace). The large value of
the 3J coupling constants is indicative of the axial orientation of
coupled protons (27); therefore, we conclude that H4 and H5
are axial, which leads to the structure shown in Fig. 5A corre-
sponding to the configuration of a D-QuiNAc ring.
NMR Analysis of the WreQ Substrate for UDP-D-QuiNAc
Synthesis—The product of the first step of the reaction, the
4-keto intermediate, was purified using TLC from the reaction
mixture containing the WbpM protein but not WreQ. Assign-
ment of NMR signals was performed in a similar fashion as for
the UDP-D-QuiNAc. The TOCSY correlation map demon-
strated that the WbpM reaction product contains two isolated
proton spin systems with signals of one assigned to H6 and
H5, whereas the second spin system included H1, H2, and H3.
TheH2 andH5 resonances overlap in the same fashion as in the
TOCSY spectra of UDP-D-QuiNAc (data not shown), but the
absence of a H6-H3 cross-peak indicates a break in the contin-
uous path for the TOCSY transfer fromH6 toH3 due to the H4
proton missing in the 4-keto intermediate.
Fig. 6B compares the one-dimensional spectra of the UDP-
D-QuiNAc and theWbpMreaction product, demonstrating the
absence of the H4 signal in the 4-keto intermediate spectrum
(bottom trace). Additionally, the H3 signal becomes a doublet,
indicating that H3 has only one 3J coupling partner in this mol-
ecule, and it must be H2. These findings confirm that the
WbpM reaction product and substrate of WreQ was, indeed,
the 4-keto-6-deoxy derivative of UDP-GlcNAc.
Direct Observation of the Reaction Progress by NMR—Stabil-
ity of the compounds in the NMR tube was directly assessed by
comparison of one-dimensional proton spectra acquired before
and after two-dimensional experiments (data not shown). Sam-
ples were found to be completely stable over the entire time of
data acquisition.
To gain information about reaction kinetics, we performed
the enzyme incubation in an NMR spectrometer and directly
monitored the WbpM-WreQ reaction progress. Initial accu-
mulation of the 4-keto intermediate and its subsequent conver-
sion into UDP-QuiNAc were monitored by 1H NMR spectros-
copy at 30 °C. Fig. 7 shows an overlay of one-dimensional
proton spectra taken during the reaction course. The initial
reaction mixture (black trace) contained UDP-GlcNAc,
NADH, and purifiedWreQ but noWbpM. Addition ofWbpM
led to quick accumulation of the 4-keto-6-deoxy intermediate
(reflecting 4,6-dehydratase activity of WbpM) as indicated by
appearance of the new H6 methyl proton doublet centered at
1.217 ppm. Activity of WreQ led to subsequent conversion of
the 4-keto-6-deoxy intermediate into UDP-QuiNAc that was
detected by the appearance of itsH6methyl doublet centered at
1.271 ppm (and decreasing H6 methyl signal of the 4-keto-6-
deoxy intermediate). Because the predicted product UDP-
QuiNAc retains the methyl group in position 6, the chemical
shift change must reflect the modification of the hexose ring at
position 4. The WbpM-catalyzed reaction was significantly
faster than that catalyzed by WreQ. Most of the 4-keto inter-
mediate was produced within the first 10 min (black to blue
traces), whereas subsequent slow conversion to UDP-QuiNAc
continued during overnight incubation and even then was not
complete (blue to red traces).
DISCUSSION
Quinovosamine was first identified in bacterial polysaccha-
rides at least 50 years ago (28, 29). Attempts to establish the
pathway of its biosynthesis foundered on the use of crude
extracts and the problem of demonstrating a specific reaction
by addingNADHto a crude extract (30).Only now,with the use
of a genetic approach leading to a facile enzyme purification,
has an enzymatic pathway for its synthesis been demonstrated
in vitro. In this report, we present evidence that UDP-QuiNAc
FIGURE 7.One-dimensional proton NMR spectra obtained from the reac-
tion mixture at different incubation times. A broad resonance at 1.241
ppm is due to methyl groups of the detergent Triton X-100 present in the
reaction mixture. This reaction was performed with 1 mM UDP-GlcNAc, 1 mM
NADH, 48g ofWbpM, and 54g ofWreQ in a total volume of 300l. WbpM
was added last to start the reaction.
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can be synthesized in vitro fromUDP-GlcNAc via the two steps
proposed previously (5) (Fig. 8).
The first step is catalyzed by UDP-GlcNAc 4,6-dehydratase,
resulting in the 4-keto intermediate UDP-2-acetamido-2,6-
dideoxy-D-xylo-4-hexulose. A soluble truncated version of the
WbpM protein from P. aeruginosa was used in this study to
catalyze this reaction in vitro (9). The R. etli CE3 wreV gene
encodes a protein that is homologous to WbpM. An insertion
mutation in wreV abolished O-antigen synthesis in R. etli, and
wbpM complemented this mutant (Fig. 9). Hence, WreV is
inferred to be the 4,6-dehydratase responsible in R. etli for the
first step of UDP-QuiNAc synthesis.
The second step in Fig. 8 is catalyzed by a 4-reductase. Pre-
vious studies (4, 5) suggested thatwreQ encodes this enzyme in
R. etli CE3. The in vitro reaction followed in this study con-
firmed that WreQ is a 4-reductase. The stereospecificity of
WreQ determines that the 4-keto intermediate is reduced to
UDP-D-QuiNAc but not to its C4 epimer UDP-N-acetyl-D-fu-
cosamine. A homolog ofWreQ in P. aeruginosaO6 encoded by
wbpV has been proposed to catalyze the same reaction (6). As
predicted, the wbpV gene can complement the R. etli wreQ
mutant (Fig. 2, A and C).
In surveying bacterial strains shown to contain D-QuiNAc
and having a sequenced genome, wreV and wreQ gene
homologs were always found and usually were closely linked on
the genomes (Table 2). Thus, biosynthesis viaWreV andWreQ
homologs may be conserved in all bacteria containing
D-QuiNAc. Conversely, the presence of D-QuiNAc in bacterial
strains could be predicted based on whether they contain the
WreV andWreQhomologs. For instance, we predict thatChlo-
robium phaeobacteroides DSM 266, Herbaspirillum seropedi-
cae SmR1, and Polaromonas naphthalenivorans CJ2 as well as
several Rhizobium and Pseudomonas strains not listed in Table
2 produce D-QuiNAc that would be found if the compositions
of their polysaccharides were to be analyzed. More examples
are given in Table 3.
The second reaction catalyzed by WreQ in Fig. 8 was rela-
tively slow. The low activity may be an artifact of one or more
features of the in vitro reaction. TheHis6-WreQprotein used in
vitro has additional amino acids at the amino terminus that
could affect structure at the active site and slow the catalysis.
Another consideration is that during dialysis to reduce the con-
centration of imidazole used in purification of the His-tagged
protein the His6-WreQ protein precipitated in the dialysis tub-
ing. It was found that adding the detergent Triton X-100 alle-
viated the precipitation, but the presence of detergent (0.1% of
reaction volume) may have affected the reaction rate. It is
unclear why His6-WreQ precipitated during dialysis. One pos-
sible explanation is that WreQ normally associates with the
membrane or other proteins in R. etli CE3 and that they are
required for its stability. If that is the case, overproduction of
WreQ in E. coli, which is devoid of its naturally associated part-
ner, may render it unstable.
The pathway intermediate, UDP-2-acetamido-2,6-dideoxy-
D-xylo-4-hexulose, was relatively stable. Although other 4-ke-
to-6-deoxy sugars have been reported to be unstable (26,
31–33), this 4-keto-6-deoxy derivative of UDP-GlcNAc was
able to withstand the purification by TLC and was stable for
several days during NMR data acquisition. Thus, we were able
to obtain both this intermediate and UDP-D-QuiNAc in stable,
relatively pure form.
Analysis of O-antigen mutants and the sequences of the wre
genes required for O-antigen have prompted speculation that
O-antigen synthesis in R. etli CE3 begins with reactions that
result in 1-pyrophospho-QuiNAc attached to a lipid carrier (8).
FIGURE 9. P. aeruginosa wbpM gene can complement R. etli wreVmutant
(CE568,wreV). Shown is silver-stained SDS-PAGE (18% gel) of LPS samples
fromwhole-cell lysates. LPS I, O-antigen-containing LPS; LPS II, core oligosac-
charide-Lipid A lacking O-antigen. CE3, wild-type R. etli strain; CE568, R. etli
strain with a gentamicin resistance cassette insertion inwreV (wreV); CE568/
pTL61, CE568 strain carrying plasmid pTL61, which expresses the full-length
WbpM.
TABLE 2
Bacterial strains that have been reported to contain D-QuiNAc and have a sequenced genome revealed R. etli CE3 WreV and WreQ protein
homologs
Bacterial strain
WreV homolog
accession no.a/E-value
WreQ homolog
accession no.a/E-value
R. etli CE3 (1)b YP_471773/0.0 YP_470339/0.0
P. aeruginosaO6 (34) AAF23989/0.0 AAF23991/2e98
Francisella tularensis subsp. tularensis SCHU S4 (35) YP_170401/2e113 YP_170399/2e28
Legionella pneumophila subsp. pneumophila str. Philadelphia 1 (36) YP_095000/2e118 YP_094797/6e74
Pseudomonas tolaasii NCPPB2192 (37) WP_016970514/0.0 WP_016971490/5e96
Vibrio vulnificusM06-24 (38) YP_004189989/0.0 YP_004189991/2e100
a Accession numbers are from genome sequencing projects except P. aeruginosaO6 for which the accession numbers were associated with Belanger et al. (6).
b References following the name of bacterial strains are studies that identified D-QuiNAc in that strain.
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As noted in the Introduction, a previous study showed that
QuiNAc was replaced by its 4-keto derivative in the LPS of the
wreQmutant strain, CE166 (5). This observation leads to ques-
tions regarding the substrate specificities of WreQ and the
putative glycosyltransferase that catalyzes initial sugar-lipid
linkage. It is conceivable that the initiator glycosyltransferase
works better with the 4-keto intermediate as substrate. If so, it
may be that the resulting lipidated sugar intermediate is a better
substrate for WreQ than the 4-keto intermediate with a UDP
moiety. This speculation provides another possible explanation
for the relatively slow catalysis ofWreQnoted in this study. The
compounds generated in vitro in this study provide an essential
starting point for answering these speculative questions.
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TABLE 3
Bacterial strains predicted to contain D-QuiNAcbasedon thepresence
of genes encoding homologs of R. etli CE3 WreV and WreQ in their
genome
WreQ was used as the query sequence in a BLAST search against the non-redun-
dant protein sequence (nr) database using the blastp algorithm. Bacterial strains
selected all meet the following criteria: 1) encode a WreQ homolog with lower
E-value than that of WbpV, 7e91 (the WreQ homolog of P. aeruginosa O6), 2)
have a fully sequenced genome, and 3) encode a WreV homolog (40 of 41 strains
contain both WreV and WreQ homologs).
Genus Species Strain
Chlorobium phaeobacteroides DSM 266
Colwellia psychrerythraea 34H
Cycloclasticus sp. P1
Gallionella capsiferriformans ES-2
Geobacter bemidjiensis Bem
sp. M21
Herbaspirillum seropedicae SmR1
Herminiimonas arsenicoxydans
Marinobacter aquaeolei VT8
Methylobacillus flagellatus KT
Methylomicrobium alcaliphilum 20Z
Methylotenera mobilis JLW8
versatilis 301
Nitrosomonas eutropha C91
Pelodictyon phaeoclathratiforme BU-1
Polaromonas naphthalenivorans CJ2
sp. JS666
Pseudomonas entomophila L48
fluorescens Pf0-1
mendocina ymp
monteilii SB3078
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